SCHEDULE 13G

Zentalis Pharmaceuticals, Inc.

Common Stock, par value $0.001 per share · CUSIP: 98943L107

Event date: 2025-01-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Millennium Management LLC

  Shares: 3,781,298.00 · Class: 5.3%

• Millennium Group Management LLC

  Shares: 3,781,298.00 · Class: 5.3%

• Israel A. Englander

  Shares: 3,781,298.00 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.